Aurinia Pharmaceuticals Inc. (AUPH) SEC Filings — 2024
16 SEC filings for Aurinia Pharmaceuticals Inc. (AUPH) in 2024.
Filings
- Aurinia Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Aurinia Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Tang Capital Discloses Stake in Aurinia Pharmaceuticals — SC 13D · Sep 12, 2024
- Aurinia Pharmaceuticals Relocates Principal Offices — 8-K · Sep 12, 2024
- Aurinia Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
- Aurinia Pharmaceuticals Files 8-K for Shareholder Votes & Financials — 8-K · Jun 14, 2024
- Aurinia Pharmaceuticals Files Proxy Supplement — DEFA14A · Jun 4, 2024
- Aurinia Pharmaceuticals Inc. DEF 14A Filing — DEF 14A · May 3, 2024
- Aurinia Pharmaceuticals Inc. Files 10-Q for Q1 2024 — 10-Q · May 2, 2024
- Aurinia Pharmaceuticals Inc. Files 10-K/A Amendment — 10-K/A · Apr 29, 2024
- ILJIN SNT Adds Group Members to Aurinia Pharma Filing — SC 13D/A · Mar 20, 2024
- Aurinia Pharma Reports Officer/Director Changes & Compensation Arrangements — 8-K · Feb 29, 2024
- Aurinia Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 15, 2024
- Aurinia Pharmaceuticals Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- BlackRock Updates Passive Stake in Aurinia Pharma — SC 13G/A · Feb 12, 2024
- Aurinia Pharma Files 8-K on Operations & Financial Condition — 8-K · Jan 5, 2024